Prostate cancer vaccine - United BiomedicalAlternative Names: LHRH vaccine - United Biomedical; SUIS-LHRH
Latest Information Update: 18 Oct 2002
At a glance
- Originator United Biomedical
- Class Cancer vaccines
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Prostate cancer
Most Recent Events
- 18 Oct 2002 No development reported - Phase-I for Prostate cancer in USA (unspecified route)
- 01 Dec 1998 Phase-I clinical trials for Prostate cancer in USA (Unknown route)